November 6, 2026

Patient Advocacy and Support

A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer a-paradigm-shift-in-oncology-fda-approves-sacituzumab-govitecan-for-metastatic-triple-negative-breast-cancer

A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

Siti Muinah July 26, 2026
The landscape of breast cancer treatment has reached a historic milestone with the recent U.S. Food and...
Read More Read more about A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer
The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship the-evolving-landscape-of-hr-positive-breast-cancer-science-treatment-and-the-path-to-long-term-survivorship

The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship

Layla Zulfa July 25, 2026
Breast cancer is not a monolithic disease; it is a complex collection of subtypes, each defined by...
Read More Read more about The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship
Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey beyond-the-baseline-how-community-and-early-detection-defined-tori-ashmans-breast-cancer-journey

Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey

Basiran July 25, 2026
In the high-stakes environment of recreational sports, the bond between teammates is often forged through sweat, competition,...
Read More Read more about Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey
The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer the-intersection-of-resilience-and-research-the-conwell-familys-battle-against-triple-negative-breast-cancer

The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer

Nila Kartika Wati July 25, 2026
Main Facts: A Journey from Diagnosis to Philanthropy At the age of 45, Jessica Conwell was a...
Read More Read more about The Intersection of Resilience and Research: The Conwell Family’s Battle Against Triple-Negative Breast Cancer
The New Frontier of Precision Oncology: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights the-new-frontier-of-precision-oncology-navigating-the-risk-of-breast-cancer-recurrence-through-genomic-insights

The New Frontier of Precision Oncology: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

Sagoh July 25, 2026
The moment a patient hears the words “you have breast cancer,” the world shifts on its axis....
Read More Read more about The New Frontier of Precision Oncology: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

You may have missed

share-your-story-a-comprehensive-guide-to-contributing-to-coping-with-cancer

Share Your Story: A Comprehensive Guide to Contributing to Coping® with Cancer

Basiran November 6, 2026
the-2027-medicare-advantage-landscape-consolidation-strategic-retreats-and-shifting-market-dynamics

The 2027 Medicare Advantage Landscape: Consolidation, Strategic Retreats, and Shifting Market Dynamics

Ali Ikhwan November 6, 2026
beyond-the-finish-line-a-new-framework-for-post-treatment-restoration-in-breast-cancer-survivors

Beyond the Finish Line: A New Framework for Post-Treatment Restoration in Breast Cancer Survivors

Azzam Bilal Chamdy November 6, 2026
navigating-the-new-frontier-glp-1-medications-and-their-complex-role-in-body-contouring-surgery

Navigating the New Frontier: GLP-1 Medications and Their Complex Role in Body Contouring Surgery

Rifan Muazin November 6, 2026